BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 8536215)

  • 1. Growth inhibitory action of brefeldin A with taxol and tiazofurin in human breast carcinoma cells.
    Yeh YA; Weber G
    Cancer Biochem Biophys; 1995 Jun; 15(1):11-7. PubMed ID: 8536215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic action of taxol with tiazofurin and methotrexate in human breast cancer cells: schedule-dependence.
    Yeh YA; Olah E; Wendel JJ; Sledge GW; Weber G
    Life Sci; 1994; 54(24):PL431-5. PubMed ID: 7910932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms in the antiproliferative action of taxol and tiazofurin.
    Olah E; Csokay B; Prajda N; Kote-Jarai Z; Yeh YA; Weber G
    Anticancer Res; 1996; 16(5A):2469-77. PubMed ID: 8917337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tamoxifen downregulates signal transduction and is synergistic with tiazofurin in human breast carcinoma MDA-MB-435 cells.
    Shen F; Weber G
    Oncol Res; 1998; 10(6):325-31. PubMed ID: 9848103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic action of taxol and tiazofurin in human ovarian, pancreatic and lung carcinoma cells.
    Taniki T; Prajda N; Monden Y; Weber G
    Cancer Biochem Biophys; 1993 Sep; 13(4):295-302. PubMed ID: 8521379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic action of tiazofurin and genistein in human ovarian carcinoma cells.
    Li W; Weber G
    Oncol Res; 1998; 10(3):117-22. PubMed ID: 9700722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergism of taxol and gallium nitrate in human breast carcinoma cells: schedule dependency.
    Hata Y; Sandler A; Loehrer PJ; Sledge GW; Weber G
    Oncol Res; 1994; 6(1):19-24. PubMed ID: 7919548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discodermolide, a cytotoxic marine agent that stabilizes microtubules more potently than taxol.
    ter Haar E; Kowalski RJ; Hamel E; Lin CM; Longley RE; Gunasekera SP; Rosenkranz HS; Day BW
    Biochemistry; 1996 Jan; 35(1):243-50. PubMed ID: 8555181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus-mediated p53 gene therapy and paclitaxel have synergistic efficacy in models of human head and neck, ovarian, prostate, and breast cancer.
    Nielsen LL; Lipari P; Dell J; Gurnani M; Hajian G
    Clin Cancer Res; 1998 Apr; 4(4):835-46. PubMed ID: 9563876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of selenium in combination with Adriamycin or Taxol on several different cancer cells.
    Vadgama JV; Wu Y; Shen D; Hsia S; Block J
    Anticancer Res; 2000; 20(3A):1391-414. PubMed ID: 10928049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rhein lysinate suppresses the growth of breast cancer cells and potentiates the inhibitory effect of Taxol in athymic mice.
    Lin YJ; Zhen YS
    Anticancer Drugs; 2009 Jan; 20(1):65-72. PubMed ID: 19343002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergism between the anticancer actions of 2-methoxyestradiol and microtubule-disrupting agents in human breast cancer.
    Han GZ; Liu ZJ; Shimoi K; Zhu BT
    Cancer Res; 2005 Jan; 65(2):387-93. PubMed ID: 15695378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Taxol and cisplatin inhibit proliferation of T47D human breast cancer cells.
    Kodali S; Burkley M; Nag K; Taylor RC; Moudgil VK
    Biochem Biophys Res Commun; 1994 Aug; 202(3):1413-9. PubMed ID: 7914723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Fatty Acid Synthase (FASN) synergistically enhances the efficacy of 5-fluorouracil in breast carcinoma cells.
    Vazquez-Martin A; Ropero S; Brunet J; Colomer R; Menendez JA
    Oncol Rep; 2007 Oct; 18(4):973-80. PubMed ID: 17786362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tiazofurin: molecular and clinical action.
    Weber G; Prajda N; Abonyi M; Look KY; Tricot G
    Anticancer Res; 1996; 16(6A):3313-22. PubMed ID: 9042306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of brefeldin A sulfide derivatives as prodrug candidates with enhanced aqueous solubilities.
    Argade AB; Devraj R; Vroman JA; Haugwitz RD; Hollingshead M; Cushman M
    J Med Chem; 1998 Aug; 41(18):3337-46. PubMed ID: 9719586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schedule-dependent synergism and antagonism between paclitaxel and methotrexate in human carcinoma cell lines.
    Kano Y; Akutsu M; Tsunoda S; Furuta M; Yazawa Y; Ando J
    Oncol Res; 1998; 10(7):347-54. PubMed ID: 10063968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance of cultured Lewis lung carcinoma cell lines to tiazofurin.
    Finlay GJ; Ching LM; Wilson WR; Baguley BC
    J Natl Cancer Inst; 1987 Aug; 79(2):291-6. PubMed ID: 3474463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of centromere dynamics by Taxol in living osteosarcoma cells.
    Kelling J; Sullivan K; Wilson L; Jordan MA
    Cancer Res; 2003 Jun; 63(11):2794-801. PubMed ID: 12782584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic action of tiazofurin and genistein on growth inhibition and differentiation of K-562 human leukemic cells.
    Li W; Weber G
    Life Sci; 1998; 63(22):1975-81. PubMed ID: 9839541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.